July 22：Public announcement on “Genetic Disease of Newborn Congenital Metabolic Disorders Screening Items,” including Phenylketonuria, Homocystinuria, Galactosemia, Congenital Hypothyroidism, Glusose-6-Phosphate Dehydrogenase Deficiency, Congenial Adrenal Hyperplasia, Maple Syrup Urine Disease, Mediumchain acyl-CoA dehydrogenase, Glutaric Aciduria type I, Isovaleric acidemia, Methylmalonic acidemia, Citrullinemia Type I, Citrullinemia Type II, 3-Hydroxy-3-Methylglutaryl CoA Lyase, Holocarboxylase Synthetase Deficiency, Propionic acidemia, Primary carnitine deficiency, Carnitine Palmitoyltransferase I Deficiency, Carnitine Palmitoyltransferase II Deficiency, Very Long-chain acyl-CoA Dehydrogenase Deficiency, and Glutaric aciduria type II, a total of 21 items were made effective since October 1st 2019.

• facebook
• line
• twitter
• plurk
• 轉寄
• 列印
• 縮短網址